Overview
These are not two versions of the same treatment. They work in opposite directions on the same system.
Testosterone therapy supplies testosterone from outside. Your body detects it, and the pituitary reduces the signals — LH and FSH — that tell your testicles to produce testosterone and sperm. Production shuts down. That includes sperm production.
Enclomiphene blocks estrogen receptors in the pituitary, which removes the brake on LH and FSH. Signaling increases, and the testicles produce more testosterone themselves. The axis stays running.
| Testosterone therapy | Enclomiphene | |
|---|---|---|
| Mechanism | Supplies testosterone directly | Stimulates your own production |
| Effect on LH and FSH | Suppressed | Increased |
| Sperm production | Suppressed — often to zero | Preserved, sometimes improved |
| Testicular size | Shrinkage is common | Maintained |
| Works if the testicles cannot respond | Yes | No — it needs a functioning axis |
| Regulatory status | FDA-approved products exist | Not FDA-approved. Compounded or off-label |
| Level of evidence | Extensive, decades | Limited; trials have not led to approval |
| Reversibility on stopping | Recovery can take months, and is not guaranteed | Levels return to baseline |
The single most important thing on this page: testosterone therapy suppresses fertility, frequently to zero sperm count, and recovery after stopping can take many months and is not guaranteed. Men are started on it every day without being told that. If you may want children, this is the conversation to have before the first prescription, not after.
Why the mechanism difference matters so much
The hypothalamic-pituitary-gonadal axis works on negative feedback. The brain monitors circulating testosterone and estradiol and adjusts LH and FSH accordingly.
Give testosterone from outside and the brain reads the level as sufficient. LH and FSH fall. The testicles, no longer receiving the signal, reduce their own production of testosterone and — because FSH drives spermatogenesis — of sperm. Testicular volume typically decreases.
Block the estrogen receptor at the pituitary and the brain under-reads the circulating signal. LH and FSH rise. The testicles are told to work harder. Testosterone rises, produced endogenously, and spermatogenesis is maintained.
Which is why the second only works if the testicles can respond. In primary testicular failure — where the problem is the testicles themselves — enclomiphene will not work, and LH and FSH will already be high, which is exactly what those tests are for. Why LH and FSH belong on the panel.
Fertility, stated properly
This deserves its own section because it is the most consequential and most under-communicated part of the decision.
Testosterone therapy suppresses spermatogenesis. In many men sperm count falls to zero. That effect is reliable enough that exogenous testosterone has been studied as a male contraceptive.
Recovery after stopping is usual but neither immediate nor guaranteed. Return of sperm production commonly takes six to twelve months, sometimes longer. A minority of men do not fully recover, and the risk appears greater with longer duration of use and with older age at starting.
Sperm banking before starting is worth discussing for any man who might want children later — including men who are confident they will not, because circumstances change and the option cannot be recovered retrospectively.
There are protocols intended to preserve or restore fertility on or after testosterone therapy. They exist, they work for many men, and they are a specialist conversation rather than something to plan from an article.
None of this makes testosterone therapy wrong. It makes it a decision that should be made with the information, and a great deal of it is currently made without.
Where enclomiphene sits
The honest summary is that it is a reasonable option in a specific situation with less evidence behind it than testosterone therapy has.
It is not FDA-approved. Clinical trials were conducted and did not result in approval. What is prescribed is compounded or supplied through off-label routes, which means it is not evaluated for consistency or purity in the way an approved product is.
The evidence is shorter-term. It raises testosterone and maintains sperm parameters in the studies available. What is much less established is whether it produces the same symptomatic benefit as testosterone therapy, and there is essentially no long-term outcome data.
It requires a working axis. In primary testicular failure it will not work, which is why LH and FSH are checked before it is considered.
It has its own effects — mood changes and visual disturbance are reported with this drug class, and visual symptoms in particular need reporting rather than tolerating.
Compounded medications are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are not equivalent to or interchangeable with any branded product.
What should happen before either
Both of these treat a diagnosis, and the diagnosis comes first.
Two morning testosterone samples, fasting, plus symptoms. A single low afternoon result is not a diagnosis.
SHBG, LH, FSH and prolactin, which separate a testicular cause from a pituitary one and change which treatment makes sense.
A search for reversible causes — obesity, sleep apnea, alcohol, opioids, thyroid disease, significant illness. Several of these are treatable, and treating them sometimes removes the question.
Baseline hematocrit and PSA, both of which are monitored on testosterone therapy. Why hematocrit specifically.
And an explicit fertility conversation, which is the one most often skipped.
Frequently asked questions
What is the difference between TRT and enclomiphene? Testosterone therapy supplies testosterone and suppresses your own production including sperm. Enclomiphene stimulates your own production and preserves fertility, but only works if the testicles can respond.
Does TRT make you infertile? It suppresses sperm production, often to zero. Recovery after stopping usually happens but can take six to twelve months or longer and is not guaranteed. This is the conversation to have before starting.
Is enclomiphene FDA-approved? No. Trials were conducted and did not result in approval. It is prescribed as a compounded or off-label preparation.
Which one is better? Neither is generally better. Testosterone therapy has far more evidence; enclomiphene preserves fertility and keeps the axis running. The right answer depends on your diagnosis, your LH and FSH, and whether fertility matters to you.
Can I switch from TRT to enclomiphene later? Men do, and it is a managed transition rather than a simple swap — the axis has been suppressed and takes time to restart. It is a clinical conversation.
Where this fits in your plan
The choice between these two is decided mostly by two things: whether your pituitary signals are already high, and whether you may want children.
Both come from the panel and the conversation before treatment rather than after — which is why we run LH and FSH as standard rather than testosterone alone. What we check.
We measure first. Then we act.
Diagnostic testing does not diagnose or rule out disease on its own and is interpreted by a licensed provider alongside your history and examination.
Ready to start your second act?
It starts with measuring, not guessing. A short, clinician-reviewed assessment shows what fits you.
This article is educational and is not medical advice. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. Individual results vary.
